Damned Heretics

Condemned by the established, but very often right

I am Nicolaus Copernicus, and I approve of this blog

I am Richard Feynman and I approve of this blog

Qualified outsiders and maverick insiders are often right about the need to replace received wisdom in science and society, as the history of the Nobel prize shows. This blog exists to back the best of them in their uphill assault on the massively entrenched edifice of resistance to and prejudice against reviewing, let alone revising, ruling ideas. In support of such qualified dissenters and courageous heretics we search for scientific paradigms and other established beliefs which may be maintained only by the power and politics of the status quo, comparing them with academic research and the published experimental and investigative record.

We especially defend and support the funding of honest, accomplished, independent minded and often heroic scientists, inventors and other original thinkers and their right to free speech and publication against the censorship, mudslinging, false arguments, ad hominem propaganda, overwhelming crowd prejudice and internal science politics of the paradigm wars of cancer, AIDS, evolution, global warming, cosmology, particle physics, macroeconomics, health and medicine, diet and nutrition.


Henry Bauer, Peter Breggin , Harvey Bialy, Giordano Bruno, Erwin Chargaff, Nicolaus Copernicus, Francis Crick, Paul Crutzen, Marie Curie, Rebecca Culshaw, Freeman Dyson, Peter Duesberg, Albert Einstein, Richard Feynman, John Fewster, Galileo Galilei, Alec Gordon, James Hansen, Edward Jenner, Benjamin Jesty, Michio Kaku, Adrian Kent, Ernst Krebs, Thomas Kuhn, Serge Lang, John Lauritsen, Mark Leggett, Richard Lindzen, Lynn Margulis, Barbara McClintock, George Miklos, Marco Mamone Capria, Peter Medawar, Kary Mullis, Linus Pauling, Eric Penrose, Max Planck, Rainer Plaga, David Rasnick, Sherwood Rowland, Carl Sagan, Otto Rossler, Fred Singer, Thomas Szasz, Alfred Wegener, Edward O. Wilson, James Watson.

Many people would die rather than think – in fact, they do so. – Bertrand Russell.

Skepticism is dangerous. That’s exactly its function, in my view. It is the business of skepticism to be dangerous. And that’s why there is a great reluctance to teach it in schools. That’s why you don’t find a general fluency in skepticism in the media. On the other hand, how will we negotiate a very perilous future if we don’t have the elementary intellectual tools to ask searching questions of those nominally in charge, especially in a democracy? – Carl Sagan (The Burden of Skepticism, keynote address to CSICOP Annual Conference, Pasadena, April 3/4, 1982).

It is really important to underscore that everything we’re talking about tonight could be utter nonsense. – Brian Greene (NYU panel on Hidden Dimensions June 5 2010, World Science Festival)

I am Albert Einstein, and I heartily approve of this blog, insofar as it seems to believe both in science and the importance of intellectual imagination, uncompromised by out of date emotions such as the impulse toward conventional religious beliefs, national aggression as a part of patriotism, and so on.   As I once remarked, the further the spiritual evolution of mankind advances, the more certain it seems to me that the path to genuine religiosity does not lie through the fear of life, and the fear of death, and blind faith, but through striving after rational knowledge.   Certainly the application of the impulse toward blind faith in science whereby authority is treated as some kind of church is to be deplored.  As I have also said, the only thing ever interfered with my learning was my education. My name as you already perceive without a doubt is George Bernard Shaw, and I certainly approve of this blog, in that its guiding spirit appears to be blasphemous in regard to the High Church doctrines of science, and it flouts the censorship of the powers that be, and as I have famously remarked, all great truths begin as blasphemy, and the first duty of the truthteller is to fight censorship, and while I notice that its seriousness of purpose is often alleviated by a satirical irony which sometimes borders on the facetious, this is all to the good, for as I have also famously remarked, if you wish to be a dissenter, make certain that you frame your ideas in jest, otherwise they will seek to kill you.  My own method was always to take the utmost trouble to find the right thing to say, and then to say it with the utmost levity. (Photo by Alfred Eisenstaedt for Life magazine) One should as a rule respect public opinion in so far as is necessary to avoid starvation and to keep out of prison, but anything that goes beyond this is voluntary submission to an unnecessary tyranny, and is likely to interfere with happiness in all kinds of ways. – Bertrand Russell, Conquest of Happiness (1930) ch. 9

(Click for more Unusual Quotations on Science and Belief)

Expanded GUIDE TO SITE PURPOSE AND LAYOUT is in the lower blue section at the bottom of every home page.

Times falls short on Bird Flu, unaware of scientific literature

16 million PubMed papers unknown to Times reporters

The New York Times science reporters and editors are operating under a severe handicap. These stalwarts are clearly unaware of the existence of PubMed, a database available courtesy of the NIH for more than a decade even on a simple home computer, which provides immediate access to the world’s stock of medical papers published in peer reviewed journals.

The database access is provided by the NIH, and will yield abstracts of the papers in a list for free to anybody interested who cares to fire up a browser and type in the word “PubMed” into a search engine. PubMed will list the papers and provide abstracts for any topic you care to ask about. If you belong to an organization like a university library you get the whole paper, not just an abstract.

This miracle is apparently as yet unknown to the New York Times, however. Their Bird Flu squad, assigned to produce a special section on Bird Flu today, evidently failed to consult this modern marvel of information in preparing their pieces. Neither the cause of this flu’s deadliness nor the ready cure for it are covered in their roundup, even though solutions to both of these puzzles are provided in the literature and have been for some time, as noted in our earlier posts on the topic.

Bird flu’s deadly power is to cause the immune system to overreact and produce Tumor Necrosis Factor or TNF in the lungs, which handicaps breathing so severely that nearly half of the unfortunate Asians who have caught it have, like the soldiers of the first World War, turned blue and died in short order.

The cure for such a cytokine storm is none other than our friendly nutritional factor, Vitamin A, in the form of carrots, fish oil and similar. Two studies showing this are out and easily found in PubMed by anyone who can get past the semi-illiterate jargon of the titles and abstracts of medical literature.

But the Times Bird Flu squad shows no sign of performing any better than the celebrated AIDS reporters and commentators of that august journal, including the hard working Larry Altman and the elegantly professorial Nicholas Wade, who despite their combined forty two years experience in the field, have not yet cottoned on the fact that HIV as a candidate for causing AIDS is about as likely as using a bicycle to get to the moon, according to the many as yet unrefuted papers of a certain Berkeley professor, as well as plain common sense.

Possibly their neglect of the scientific literature in both fields has to do with the pain of wading through the jargon which is the stock in trade of professionals in these fields, which is only really interesting when you realize that it conceals ignorance and illogic, almost as often as it conveys good information, in these two fields.

Surely it is distasteful to men whose main role in life is writing elegantly clear exposition for the readers of the Times to have to chew on literary concrete any more than they have to. With both of them evidently unaware that the theory of HIV was scuttled by unanswerable objections almost as soon as it left the launch ramp and splashed into the sea of ignorance and dutiful stenography that allows almost any claim by scientists to win immediate acceptance in the media, they lack the motivation to read any more of the standard literature than they have to in AIDS, and presumably are similarly disinclined to tackle any more of the bird flu papers than they have to, also.

Well, we don’t necessarily blame them. It is hard for middle aged men to catch up with the new toys of the new era. We doubt if either of them own an iPod, or do much text messaging. The PubMed data base is probably equally alien and incomprehensible to these traditional literary folk.

And after all, the officials of the NIH don’t appear to be setting any better example. Although we tipped him off four months ago NIAID director Anthony Fauci and his cohorts still seem unaware that they could save $7 billion by simply asking one of their secretaries to point a browser at the very data base which their own institution has bestowed upon the American people, miraculously transforming every kid or blogger with a keyboard into a medical authority more informed than the combined staff of Cornell and the Mayo Clinic.

PubMed is Easy to Use

Simply enter your search topics – one or more terms – and click Go. PubMed can be searched using MeSH terms, author names, title words, text words or phrases, journal names, or any combination of these. Retrieved citations are displayed and their associated abstracts can be selected for viewing. A unique feature of PubMed is the ability to instantly find related articles for any citation.

Additional search modes offer the ability to perform more complex searches by specifying data fields, age groups, gender, or human or animal studies. A special clinical queries page provides customized searches for studies based on etiology, diagnosis, prognosis, or treatment of a particular disease. Systematic reviews of a topic and medical genetics can also be searched here. Search results can be viewed or downloaded in various formats, including a format suitable for bibliographic management software.

PubMed’s LinkOut feature provides access to a wide variety of relevant web-accessible online resources, including full-text publications, biological databases, consumer health information, research tools, and more. Currently citations from more than 4,600 journals are linked to the full-text on publishers’ web sites. Users may have to register, or there may be a fee or subscription required to access the full-text.

Here is the overall Times guide to Avian Influenza, pages which contain all the articles in the Science section today.

The CDC has plenty of relevant articles on its own web site, if that is easier for Tony Fauci or Nicholas Wade to deal with. Just type “cytokine” into the CDC search slot, gentlemen, and you’ll find papers such as this one, the fifth listed. Not that the CDC has been very alert in its own use of PubMed. The paper was written in July last year, but according to the dating the CDC finally found it and listed it little more than a week ago, on March 21, 2006. Evidently the staff of the CD are almost as PubMed challenged as the NIH or the Times.

The paper (as we noted in our original November 20 post here nearly five months ago) explains that bird flu’s A-H5N1 virus occupies the lungs and intestines primarily and creates Tumor Necrosis Factor-α (TNF-α) in the lungs in a cytokine storm produced by an overreaction of the immune system.

It’s title is
“>Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis [serial on the Internet]. 2005 Jul [date cited].

Here is the entire text.


Past Issue

Vol. 11, No. 7

July 2005

Influenza A H5N1 Replication Sites in Humans

Mongkol Uiprasertkul,* Pilaipan Puthavathana,* Kantima Sangsiriwut,* Phisanu Pooruk,* Kanittar Srisook,* Malik Peiris,† John M. Nicholls,† Kulkanya Chokephaibulkit,* Nirun Vanprapar,* and Prasert Auewarakul*

*Mahidol University, Bangkok, Thailand; and †University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China

Suggested citation for this article

Tissue tropism and pathogenesis of influenza A virus subtype H5N1 disease in humans is not well defined. In mammalian experimental models, H5N1 influenza is a disseminated disease. However, limited previous data from human autopsies have not shown evidence of virus dissemination beyond the lung. We investigated a patient with fatal H5N1 influenza. Viral RNA was detected by reverse transcription–polymerase chain reaction in lung, intestine, and spleen tissues, but positive-stranded viral RNA indicating virus replication was confined to the lung and intestine. Viral antigen was detected in pneumocytes by immunohistochemical tests. Tumor necrosis factor-α mRNA was seen in lung tissue. In contrast to disseminated infection documented in other mammals and birds, H5N1 viral replication in humans may be restricted to the lung and intestine, and the major site of H5N1 viral replication in the lung is the pneumocyte.

Highly pathogenic avian influenza virus H5N1 is the first avian influenza virus that was documented to cause respiratory disease and death in humans (1–3). In 2004, it caused widespread disease in poultry in Asia (4) and led to human disease in Thailand and Vietnam, with reported fatality rates of 66% and 80%, respectively (5,6). With the emergence of a second wave of disease outbreaks in poultry in Thailand, Vietnam, and Indonesia, this disease poses a global threat to human health (4). Additional human cases have been reported since August 2004. The high pathogenicity of this virus in avian species is associated with readily cleavable hemagglutinin (HA), but other amino acid residues in HA and neuraminidase have been recently reported to be involved in avian pathogenicity (7). In mice, some H5N1 virus strains cause a disseminated infection and death, and this phenotype was associated with specific amino acid substitutions in PB2 and the multibasic cleavage site in HA (8). Natural infection of felines with H5N1 viruses also resulted in disseminated infection (9). However, the pathogenesis of H5N1 disease in humans is more obscure. Despite severe and generalized clinical manifestations, the result of multiple organ dysfunction, previous limited autopsy data failed to show evidence of viral replication beyond the respiratory tract (10,11). The tissue tropism of the virus in humans has also not been clearly established by immunohistochemical analyses (10,11). The absence of detectable viral antigen–positive cells in previous reports may relate to the fact that the patients died during the late phase of the disease after intensive treatment with antiviral drugs. In this report, we investigated a case of fatal H5N1 disease in a child for tissue tropism caused by the virus in the lungs and other organs.


Patient and Virologic Diagnosis

Detailed clinical description of the patient is reported elsewhere (12). The patient was a 6-year-old boy who had a progressive viral pneumonia that led to acute respiratory distress syndrome and death 17 days after onset of illness. He was initially treated with multiple broad-spectrum antimicrobial agents. Virologic diagnosis of H5N1 infection was made on day 7 of illness. After oseltamivir became available in Thailand, he was treated on day 15 of his illness with this agent until he died. He was also treated with methylprednisolone on day 15 until death and with granulocyte colony-stimulating factor for leukopenia from day 5 to day 10 of illness.

Virologic diagnosis was made by antigen detection, viral culture, and reverse transcription–polymerase chain reaction (RT-PCR) on a nasopharyngeal wash specimen as described (12) and was confirmed by seroconversion of neutralizing antibody against H5N1 virus. The virus was identified as avian influenza virus (H5N1) by whole genome sequencing. The virus was an avian virus with no evidence of genetic reassortment with human influenza viruses. Phylogenetic analysis showed that the viral genomic sequence formed a distinct cluster with other H5N1 viruses isolated from humans and poultry in Thailand and Vietnam, but it was still related to the previously described H5N1 viruses circulating in southern China. As with other viruses isolated from poultry in Vietnam, Thailand, and Indonesia, this virus was also a genotype Z virus (4).

Pathologic Examination

Autopsy was carried out by standard techniques, and precautions were taken to minimize risk of transmission of infection. The tissue obtained was prepared for routine histologic analysis, and a portion was stored at –70°C for further study. For RT-PCR, fresh unfixed specimens were minced into small pieces in lysis buffer of an RNA extraction kit (RNA Wizard, Ambion, Austin TX, USA). Total RNA was then extracted according to the manufacturer’s protocol. RNA was also extracted from paraffin-embedded tissues by sequential extraction with TriZol reagent (Invitrogen, Carlsbad, CA, USA) and the RNAEasy kit (Qiagen, Valencia, CA, USA) after digestion with proteinase K. RT-PCR for H5 was then conducted on extracted RNA by using One Step RT-PCR kit (Qiagen) with the H5 specific primer pairs H5F (5´-ACTCCAATGGGGGCGATAAAC-3´) and H5R (5´-CAACGGCCTCAAACTGAGTGT-3´) (13). An RT-PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was done in parallel to control for the amount and quality of RNA as described (14). Strand-specific RT-PCR was carried out by a method similar to RT-PCR for viral RNA detection, except that only 1 primer was added at the reverse transcription step.

For immunohistochemical analysis, sections were deparaffinized and rehydrated. Antigenic site retrieval was accomplished by heating each slide in a microwave oven at 700 W for 15 min in 0.05 mol/L citric acid buffer, pH 6.0, and cooling for 20 min at room temperature. Endogenous peroxidase activity was blocked by incubating the slides in 0.3% H2O2 for 30 min at room temperature. Sections were incubated with 20% normal goat serum (Dako, Glostrup, Denmark) for 20 min at room temperature and then with an anti-influenza A nucleoprotein monoclonal antibody at a 1:100 dilution (B.V. European Veterinary Laboratory, Woerden, the Netherlands) for 1 h at room temperature. Slides were rinsed 3 times in 0.05 mol/L Tris-buffer, pH 7.6, 0.1% Tween 20 and incubated with horseradish peroxidase–conjugated goat anti-mouse immunoglobulin at a 1:400 dilution (Dako) for 30 min at room temperature. The slides were washed as above, developed with diaminobenzidine (Dako), and counterstained with hematoxylin. Some slides of lung tissue were double-stained with a monoclonal antibody (1:50 dilution) against surfactant (Dako).

Cytokine Expression

Tumor necrosis factor-α (TNF-α), interferon- (IFN-γ), and interleukin-6 (IL-6) mRNA were detected in the extracted RNA by an RT-PCR with previously described primer pairs (15–17). Plasma levels of TNF-α and IFN-γ were measured by enzyme-linked immunosorbent assay (Pierce Endogen, Rockford, IL, USA) and compared with samples from 3 H3 influenza–infected patients and 5 healthy persons.


Figure 1

Click to view enlarged image

Figure 1. Microscopic shape of the lung showing proliferative phase of diffuse alveolar damage and interstitial pneumonia…

Figure 2

Click to view enlarged image

Figure 2. A) Detection of H5 influenza viral RNA in lungs, intestines, and spleen by reverse transcription–polymerase chain reaction…

Figure 3

Click to view enlarged image

Figure 3. Immunohistochemical analysis showing influenza A antigen-specific staining in nuclei of cells lining the alveoli (A)…

The autopsy showed proliferative phase of diffuse alveolar damage, interstitial pneumonia, focal hemorrhage, and bronchiolitis. The pneumocytes showed reactive hyperplasia without virus-associated cytopathic changes (Figure 1). Superimposed infection by fungus, morphologically consistent with aspergillosis, was seen in some areas of the lung. The lymph nodes, spleen, and bone marrow showed slight histiocytic hyperplasia. No evidence of hemophagocytic activity was seen. The liver had mild fatty changes, activated Kupffer cells, and slight lymphoid infiltration in the portal areas. The brain was edematous, and small foci of necrosis were found. Intestines, kidneys, heart, and other organs showed no remarkable changes.

H5-specific RNA was detected in the lung, spleen, and small and large intestines by RT-PCR (Figure 2A). Control reactions without the reverse transcription step were negative, confirming that the PCR amplicon was not contaminated. The successful extractions of RNA from all organs were confirmed by the amplification of GAPDH mRNA (data not shown). We also tested whether the RNA was genomic RNA from virion or replicating RNA and mRNA from productively infected cells. To determine this, we conducted strand-specific RT-PCRs. Positive- and negative-stranded viral RNA was found in the lung, small intestines, and large intestines, but only negative-stranded RNA was detected in the spleen (Figure 2B). Because of the absence of positive-stranded RNA, which would serve as mRNA and the template for genome replication, we concluded that viral replication was absent or very low in the spleen and that the viral RNA detected in the spleen was probably nonreplicating virion RNA. No evidence of viral RNA was seen in the adrenal glands, brain, bone marrow, kidneys, liver, or pancreas. Results of the RT-PCR for viral RNA in plasma were also negative.

Immunohistochemical analysis detected influenza A virus antigen-positive cells in lung tissue. The staining was localized in nuclei of alveoli-lining cells. Positive cells were found in 4 of 9 blocks of lung tissue. The shape and location of the antigen-positive cells indicated that they were type II pneumocytes. To confirm this, we used surfactant as a marker of type II pneumocyte (18). We double-stained slides from adjacent cuts with anti-influenza A and anti-surfactant monoclonal antibodies and showed that all influenza virus antigen–positive cells with nuclear staining showed intracytoplasmic staining of surfactant (Figure 3). Slides stained only with antibodies to surfactant showed intracytoplasmic, not intranuclear, staining. This finding confirmed that viral antigen–positive cells were type II pneumocytes. Although viral mRNA was present in the intestines, viral antigen was not detected in 4 blocks of tissue from the small and large intestines. In accordance with the absence of viral mRNA in other organs, viral antigen was not detected in those tissues. We also tested 2 blocks of tissue from the trachea. We did not detect any positive staining in columnar epithelium, which is the usual target for influenza virus infection in humans (19), which suggests that the virus targeted primarily lung tissue and not airway epithelium. Similarly, we did not find viral antigen in bronchiolar epithelium in the lung sections. Columnar epithelium in both the trachea and bronchiole was intact, thus providing adequate columnar epithelial cells for evaluation. The lack of pathologic changes is consistent with the absence of viral infection in these tissues.

The high pathogenicity of the H5N1 avian influenza virus has been proposed to be caused by induction of proinflammatory cytokines (20). Cytokine dysregulation could be the major cause of tissue damage in humans, especially in organs in which productive infection does not take place and cell damage cannot be accounted for by cytolytic viral infection. To investigate this aspect of viral pathogenesis, we tested for the presence of cytokine mRNA in tissues from various organs. We detected TNF-α mRNA in lung tissue, but not in other organs (intestines, stomach, spleen, brain, bone marrow, kidneys, liver, and pancreas) of this patient, or in lung tissue of patients who died of other causes (Figure 2C). We did not find any increase in levels of IFN-α, IFN-γ, and IL-6 mRNA in organs of this patient when compared with control tissues from healthy persons.

In accordance with previous reports showing the increased levels of serum cytokines, we found high levels of interferon-induced protein 10 in serum samples collected on day 5 (37,000 pg/mL) and day 10 (4,300 pg/mL) of illness. These levels are comparable to those reported in H5N1-infected cases (10). However, we could not detect any significant levels of TNF-α and IFN-γ in these samples.


Detailed autopsy data on patients with H5N1 disease are limited, and our data provide an insight into the pathogenesis of H5N1 virus in humans. We provide evidence that H5N1 viral replication is not confined to the respiratory tract but may also occur in the gastrointestinal tract. However, a fecal sample was not available for detection of virus. Although viral RNA was detected in the spleen, no evidence of viral replication was seen in this organ. The patient was treated with an antiviral agent for 2 days before death, which could have lowered the level of viral replication in the examined tissues. However, we still found viral mRNA in lungs and intestines, indicating that the viral replication was still ongoing. Viral replication in lungs and intestines was greater than in other sites. Our data agree with previous reports of human cases and cases in experimentally infected macaques, which also suggest that H5N1 influenza virus replication takes place predominantly in the lungs (10,11,21). We also show that type II pneumocytes, not columnar tracheal epithelial cells, are the major site of H5N1 viral replication in humans. Type II pneumocytes are surfactant-producing, alveolar epithelial cells and progenitor cells of both type I and type II cells. This cell type has been shown to contain sialic acid in newborn human lung (22). Whether the availability of the receptor alone determined the site of H5N1 infection needs further investigation.

Infection of the gastrointestinal tract by avian influenza virus, including H5N1, is common in avian species (23,24). However, involvement of the gastrointestinal tract in H1 and H3 influenza infection is rare in humans (25). A patient with H5N1 influenza virus infection was reported to have diarrhea as the initial symptom, which raises the question of whether the gastrointestinal tract may is another site of viral replication and shedding, similar to its function in avian species (26). In another recent report of a patient with a fatal H5N1 infection and severe diarrhea and encephalitis in Vietnam, the virus was found in a rectal swab (27). Our data confirm that H5N1 influenza virus replication can occur in the gastrointestinal tract even in the absence of diarrhea. However, we do not know the extent of viral shedding in stool in this patient. The absence of pathologic changes in the intestine, despite the viral replication, is intriguing.

The absence of viral antigen in the trachea indicated that the upper airway is probably not an active site of the viral replication. This finding is in marked contrast to the circumstances with human influenza, in which the upper respiratory tract and the tracheal and bronchial epithelium are primarily targeted (19). The predilection of H5N1 influenza virus for the lower airways may explain why detecting virus in upper airway specimens for diagnosis of H5N1 infection in humans is difficult (1). This finding also implies that specimens from the lower respiratory tract, such as sputum or bronchoalveolar lavage, would have a higher sensitivity for viral detection than an upper respiratory specimen, such as nasopharyngeal aspirates or throat swab specimens. Our data showing the absence of viral antigen in columnar epithelial cells contrast with a recently published report that H5N1 viral replication took place selectively in ciliated bronchial epithelial cells in an in vitro culture model (28). Whether this result was due to properties of specific viral strains or a difference attributable to the in vitro model needs further clarification.

In contrast to previous reports (10,11), we did not find prominent hemophagocytosis in any of the organs. The presence of hemophagocytosis in these reports supports the cytokine dysregulation model of pathogenesis. Whether the young age of our patient or prior treatment with immunosuppressive corticosteroids affected this manifestation in this patient is unclear.

TNF-α mRNA was detectable in the lungs but not in other tissues. This finding is in agreement with previous observations that H5N1 viruses isolated from human disease hyperinduce production of cytokines, most prominently TNF-α, in cultured human macrophages in vitro (20,29). The simultaneous presence of viral mRNA and cytokine mRNA in the same organ suggests a direct induction of cytokine in productively infected cells. In accordance with this finding, we also found that the viral isolate from this patient induced a high level of TNF-α production from primary human macrophages, which is comparable to the previously described strains (M. Peiris, unpub. data). However, we could not rule out the possibility that the superimposed fungal infection might have played a role in the induction of TNF-α in this patient. The hemagglutinin of the 1918 pandemic H1N1 influenza virus also appears to hyperinduce production of cytokines and chemokines in a mouse model of disease (30).

In conclusion, we have documented that H5N1 disease in humans is one in which viral replication is restricted to the respiratory and gastrointestinal tracts. The multiorgan dysfunction observed in human H5N1 disease, despite the apparent confinement of infection to the lungs, has remained an enigma. The hypothesis that cytokine dysregulation may contribute to the pathogenesis of severe H5N1 disease (20) remains a possibility. An understanding of the pathogenesis of human H5N1 disease is important in preparing for a pandemic.


We thank Kobporn Bunnak and Raweewan Khanyok for expert technical assistance.

This study was supported by a research grant from the National Center for Genetic Engineering and Biotechnology of Thailand.

Dr. Uiprasertkul is a pathologist at the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok. His primary research interest is the pathogenesis of viral diseases.


Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467–71.

Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 1998;279:393–6.

Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351:472–7.

Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:209–13.

Grose C, Chokephaibulkit K. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr Infect Dis J. 2004;23:793–4.

Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350:1179–88.

Hulse DJ, Webster RG, Russell RJ, Perez DR. Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J Virol. 2004;78:9954–64.

Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2.

Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, et al. Avian H5N1 influenza in cats. Science. 2004;306:241.

Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363:617–9.

To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001;63:242–6.

Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF, et al. A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J. 2005;24:162–6.

Poddar SK. Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis. J Virol Methods. 2002;99:63–70.

Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene. 1997;15:2145–50.

Richtsteiger R, Henke-Gendo C, Schmidtke M, Harste G, Heim A. Quantitative multiplex real-time PCR for the sensitive detection of interferon beta gene induction and viral suppression of interferon beta expression. Cytokine. 2003;24:190–200.

Blaschke V, Reich K, Blaschke S, Zipprich S, Neumann C. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods. 2000;246:79–90.

Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, et al. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother. 2004;53:786–92.

van Golde LM, de Vries AC, Batenburg JJ. Aspects of metabolism and storage of pulmonary surfactant: experiments with isolated type II pneumocytes and lamellar bodies. Eur J Respir Dis. 1987;153:182–8.

Hers JF. Disturbances of the ciliated epithelium due to influenza virus. Am Rev Respir Dis. 1966;93(Suppl):162–77.

Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet. 2002;360:1831–7.

Kuiken T, Rimmelzwaan GF, van Amerongen G, Osterhaus AD. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet Pathol. 2003;40:304–10.

Cerna A, Janega P, Martanovic P, Lisy M, Babal P. Changes in sialic acid expression in the lung during intrauterine development of the human fetus. Acta Histochem. 2002;104:339–42.

Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology. 1978;84: 268–78.

Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology. 1998;252:331–42.

Zinserling AV, Aksenov OA, Melnikova VF, Zinserling VA. Extrapulmonary lesions in influenza. Tohoku J Exp Med. 1983;140:259–72.

Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, et al. Atypical avian influenza (H5N1). Emerg Infect Dis. 2004;10:1321–4.

de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352:686–91.

Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A. 2004;101:4620–4.

Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A. 2004;101:8156–61.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature. 2004;431:703–7.

Suggested citation for this article:

Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis [serial on the Internet]. 2005 Jul [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol11no07/04-1313.htm

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Prasert Auewarakul, Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkok 10700, Thailand; fax: 66-2-418-4148; email: sipaw@mahidol.ac.th

If this paper, which is intelligible to any layman as far as we can judge, is too difficult for a Times editor or reporter to understand, they can always contact the author for further explanation – Prasert Auewarakul, Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkok 10700, Thailand; fax: 66-2-418-4148; email: sipaw@mahidol.ac.th

Seems to us that even a Times reporter, even one of Wade’s baffling inability to handle a theoretical challenge to HIV over two decades, should be able to understand this sentence, at least:

TNF-α mRNA was detectable in the lungs but not in other tissues. This finding is in agreement with previous observations that H5N1 viruses isolated from human disease hyperinduce production of cytokines, most prominently TNF-α, in cultured human macrophages in vitro.

Of course, then the question becomes, what is the antidote for a cytokine storm of TNF in the lungs? According to the CDC easy guide to Avian Influenza, their staff have no idea, since the advice about treatment is no different than for regular flu:

How is avian influenza in humans treated?

Studies done in laboratories suggest that the prescription medicines approved for human influenza viruses should work in treating avian influenza infection in humans. However, influenza viruses can become resistant to these drugs, so these medications may not always work. Additional studies are needed to determine the effectiveness of these medicines.

In other words, they haven’t a clue that in the last year not one but two studies have been published confirming what other papers have already established, which is that a little Vitamin A does very nicely in knocking out this rather unpleasant phenomenon which otherwise would result in termination of the patient’s breathing ability.

This may be because nutritional factors do not interest the CDC or the Times since they have not much to do with the great engine that drives the bulk of disease research these days, the enduring hope that a profit making drug will be the answer. We have no idea, of course, whether this scurrilous speculation has any truth to it.

However, we should point out that as we have mentioned before the nutritional approach in this case is respectable to a degree that even the Times and CDC cannot argue with, namely, the Harvard School of Public Health.

The paper to refer to is Effects of Vitamin A Supplemnentation on Immune Responses and Correlation with Clinical Outcomes, from Clinical Microbiology Reviews, July 2005, pages 446-464, by the estimable Eduardo Villamor and Wafaie W. Fawzi.

If any of the staff of the Times or the CDC, or for that matter Tony Fauci or his secretary, wish to phone up Eduardo and get the gen from the horse’s mouth, his telephone is 617-432-1238. His email is evillano@hsph.harvard.edu.

Since the cost of a phone call these days is a few cents, and the potential saving to the US and the governments of the rest of the world would probably approach $10 billion, not even counting the economic loss from bird flu panic if the flu is detected in the US, let alone the lives of birds around the world currently threatened with execution though suffocation or being burned alive, and not to mention the dispiriting prospect of chicken off the menu of all but the most expensive restaurants, we hope that it will be made.

Of course, if Anthony Fauci wishes to send even a fraction of this saving our way, we will not be embarrassed.

One Response to “Times falls short on Bird Flu, unaware of scientific literature”

  1. Robert Houston Says:

    You’re right, Truthseeker. The NY Times for all its verbiage has missed the main discoveries regarding avian flu. Its website allows one to search at once all 207 articles they’ve ever published on the subject. None of these articles mentions “cytokine”, “TNF”, or “vitamin.”

    Yet the major finding from the foremost avian flu research center in the world is that the H5N1 virus is distinguished from milder flu viruses by its ability to hyperinduce the production of tumor necrosis factor (TNF) and other proinflammatory cytokines in the cells of the immune system, particularly the macrophages. This discovery, from the University of Hong Kong Dept. of Microbiology, was extended last August to specify the main mechanisms (1). Meanwhile, in nearby Taiwan, government scientists reported at about the same time that the main metabolite of vitamin A “could reduce…TNF-a production” and that “vitamin A may protect…patients from proinflammatory cytokine-mediated damage” (2). These findings were reported exclusively by Truthseeker last November (click HERE for his world scoop).

    The ability of vitamin A to inhibit TNF in macrophages had long been known. Researchers at M.D. Anderson Cancer Center reported in 1994 that the major vitamin A metabolite “almost completely inhibited the production of TNF by macrophages” (3).

    The Harvard review of Vitamin A mentioned above does not cite any of these studies but does review a number of other studies showing that vitamin A inhibits TNF (see section on Monocytes and Macrophages). It also references a clinical trial from Norway, which found that vitamin A supplementation at 6500 units a day (slightly above the daily requirement) resulted in “a significant decrease in TNF-a levels” – actually cutting them in half (4). Significant inhibition of TNF was also found in clinical trials of vitamin A (and other antioxidant vitamins) conducted in Italy (5) and Greece (6).

    1. D. Lee et al. Hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J. Virol. 79:10147-54, Aug. 2005.

    2. L. Ho et al. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production… Biochem. Pharmac. 70:200-8, 2005.

    3. K. Mehta et al. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J. Leukoc. Biol. 44:336-42, 1994.

    4. P. Aukrust et al. Decreased vitamin A levels in common variable immunodeficiency. Eur. J. Clin. Inv. 30:252-259, 2000.

    5. G. Mantovani et al. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Cell. Mol. Med. 6:507-82, 2002.

    6. T. Vassilakopoulos et al. Antioxidants attenuate the plasma cytokine response to exercise in humans. J. Appl. Physiol. 94:1025-32, 2003.

Leave a Reply

You must be logged in to post a comment.

Bad Behavior has blocked 302 access attempts in the last 7 days.